Current Cancer Therapy Reviews

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany

Back

Become EABM
Become Reviewer

Open Access Articles

Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy open Access plus

Volume: 15  
Pp: 1-8
Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph Drabick and Heath Mackley*
DOI:10.2174/2542584601666180326111906

Solanum Nigrum Anticancer Effect Through Epigenetic Modulations in Breast Cancer Cell Lines open Access plus

Volume: 15  
Pp: 1-6
Atefeh Shirkavand, Zahra Niki Boroujeni and Seyed Ahmad Aleyasin*
DOI:10.2174/1573394715666190101114541

Possible Biomarkers and Therapeutic Targets for the Management of Cervical Cancer open Access plus

Volume: 15  
Pp: 1-14
Sombeer Sharma*, Aakash Deep, A C Rana and Monu Yadav
DOI:10.2174/1573394715666190126142508

The Prognostic Value of Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma in Iranian Population open Access plus

Volume: 15  
Pp: 1-6
Mohammadreza Mirinezhad, Narjes Khalilipour, Reza Raoofian and Mohammad Reza Abbaszadegan*
DOI:10.2174/1573394715666190206162002

Exploring Promises of siRNA in Cancer Therapeutics open Access plus

Volume: 15  
Pp: 1-7
Mahima Kaushik*, Rddhima Raghunand and Shobhit Maheshwari
DOI:10.2174/1573394715666190207130128

Overview of Modern Surgical Management of Central Nervous System Tumors: North American Experience open Access plus

Volume: 15  
Pp: 1-14
Adam Wu*
DOI:10.2174/1573394715666190212112842

Demographic and Clinical Evaluation of Patients with Pancreatic Cancer in Mashhad University of Medical Sciences During 2002-2013 open Access plus

Volume: 15  
Pp: 1-9
Mina Akbari Rad, Azar Fanipakdel, Hassan Vossoughinia, Maliheh Dadgarmoghaddam, Benyamin Esmaeili, Amir Hossein Jafarian, Masoumeh Salari* and Abdollah Firoozi
DOI:10.2174/1573394715666190422123430

Virtual Screening of Novel Hybrid Non-Steroidal Anti-inflammatory drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an Insilico Approach open Access plus

Volume: 15  
Pp: 1-8
Ashish P Shah* and Chhagan N Patel
DOI:10.2174/1573394715666190618114748

Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review open Access plus

Volume: 15  
Pp: 1-11
Dheyauldeen Shabeeb, Mansoor Kashavarz , Ahmed Eleojo Musa , Ehsan Mihandoost , Gholamreza Hassanzadeh , Mohammed Reza Hadian, Alireza Shirazi and Masoud Najafi *
DOI:10.2174/1573394715666190724102937

Molecular Pathways, Screening and Follow–up of Colorectal Carcinogenesis: An Overview open Access plus

Volume: 15  
Pp: 1-9
Amirhossein Sahebkar *, Eskandar Taghizadeh, Seyed Mohammad Gheibi Hayat, Rhonda J. Rosengren and Hamed Abdolkarimi
DOI:10.2174/1573394715666190730111946

Development, Characterization and Anticancer Evaluation of Silver Nanoparticles from Dalbergia Sissoo Leaf Extracts open Access plus

Volume: 15  
Pp: 1-7
Aakash Deep*, Mitali Verma, Rakesh Kumar Marwaha, Arun Kumar and Beena Kumari
DOI:10.2174/1573394715666190820150651

A Comparison of Ultrasound and Fluoroscopy- Guided Celiac Plexus Neurolysis in Patients With Pancreatic Cancer open Access plus

Volume: 15  
Pp: 1-7
Khadeja M. Elhossieny, Waseem M. Seleem, Sherief Abd-Elsalam*, Tamer Haydara and Nashwa Mohamed El gharbawy
DOI:10.2174/1573394715666190904091145

New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment open Access plus

Volume: 15  
Pp: 1-14
Xinjia He, Qiaqia He*, Lihua Wang and Xiaofei He
DOI:10.2174/1573394715666190906125014

Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment open Access plus

Volume: 15  
Pp: 1-8
Kawalpreet Kaur and Gopal L. Khatik*
DOI:10.2174/1573394715666190913184853

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target open Access plus

Volume: 13   Issue: 2
Pp: 76-88
Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*
DOI:10.2174/1573394713666170907160734

In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells open Access plus

Volume: 13   Issue: 2
Pp: 129-136
Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi
DOI:10.2174/1573394713666170712113049

Non-Melanoma Skin Cancer – Overview open Access plus

Volume: 12   Issue: 3
Pp: 142-151
Kurian Joseph
DOI:10.2174/1573394713666161214124214

Roles of Tumor Microenvironment in Hepatocelluar Carcinoma open Access plus

Volume: 11   Issue: 2
Pp: 82-93
Haeng R. Seo
DOI:10.2174/1573394711666151022203313

Trends in Malignant Glioma Monoclonal Antibody Therapy open Access plus

Volume: 11   Issue: 2
Pp: 102-118
Ivan Chekhonin and Olga Gurina
DOI:10.2174/1573394711888150917142941

Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers open Access plus

Volume: 9   Issue: 4
Pp: 265-277
Ana Paula Delgado, Pamela Brandao, Sheilin Hamid and Ramaswamy Narayanan
DOI:10.2174/1573394710666140313003905

Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine open Access plus

Volume: 6   Issue: 2
Pp: 126-137
Nathalie Garcon and Oberdan Leo
DOI:10.2174/157339410791202574

Clinical Development of MET Targeted Therapy For Human Cancer open Access plus

Volume: 5   Issue: 4
Pp: 261-270
Nima Tirgan, Zhe Tang and Patrick C. Ma
DOI:10.2174/157339409789712708

Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options open Access plus

Volume: 5   Issue: 4
Pp: 232-242
Albrecht Reichle
DOI:10.2174/157339409789712690

Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy open Access plus

Volume: 5   Issue: 2
Pp: 111-121
Nagendra K. Prasad
DOI:10.2174/157339409788166779

Runx1/AML1 is a Guardian of Hematopoietic Stem Cells open Access plus

Volume: 4   Issue: 3
Pp: 188-195
Lena Motoda, Motomi Osato and Yoshiaki Ito
DOI:10.2174/157339408785294302